Laura Smith
Family · Billings, MTNPI 1902541998
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,556 of the $2,575 with a category attached, or 60.4%. Boston Scientific accounts for 63.7% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $1,443, more than ten times the $142 reported in 2022. Among family clinicians in MT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 27 payments — averaging $95.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Actelion Pharmaceuticals US, Inc.$272
- Impulse Dynamics (USA) Inc.$119
- Baxter Healthcare$80
- Medtronic$77
- AstraZeneca$74
- plus $312 from 7 others
Across 1 payment — averaging $426.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$426
What the payments were for
- Travel & lodging$1,02040%
- Food & beverage$1,55660%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 13 | $1,642 |
| Actelion Pharmaceuticals US, Inc. | 2 | $272 |
| Impulse Dynamics (USA) Inc. | 1 | $119 |
| Baxter Healthcare | 1 | $80 |
| Medtronic | 1 | $77 |
| AstraZeneca | 2 | $74 |
| Merck | 1 | $69 |
| Edwards Lifesciences | 1 | $69 |
| Pfizer | 1 | $63 |
| Johnson & Johnson | 1 | $50 |
| Novartis | 1 | $24 |
| Abiomed | 1 | $24 |
| Cardiva Medical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$926
- UPTRAVI$272
- OPSUMIT$272
- OPTIMIZER$239
- WATCHMAN Access System$147
- CDS broad portfolio offering$122
- WATCHMAN FLX$115
How this compares
$2,575 in reported general payments places this provider in the 90th percentile of 481 family providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 165 | $130,094 |
| EliquisApixaban | 128 | $118,930 |
| EntrestoSacubitril/Valsartan | 68 | $80,167 |
| FarxigaDapagliflozin Propanediol | 47 | $58,487 |
| XareltoRivaroxaban | 15 | $15,202 |
| Metoprolol Succinate | 357 | $4,696 |
| Potassium Chloride | 179 | $4,651 |
| Bumetanide | 36 | $2,529 |
| Spironolactone | 315 | $2,324 |
| Atorvastatin Calcium | 205 | $2,052 |
| Losartan Potassium | 185 | $1,794 |
| Torsemide | 84 | $1,748 |
| Carvedilol | 142 | $1,214 |
| ClopidogrelClopidogrel Bisulfate | 87 | $1,076 |
| Furosemide | 182 | $836 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $63 | $118,930128 claims |
| NovartisEntresto | $24 | $80,16768 claims |
| AstraZenecaFarxiga | $74 | $58,48747 claims |
| Johnson & JohnsonXarelto | $50 | $15,20215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 481 family providers in Montana.
Other family in Billings
- Lacy TangedahlBillings$31K
- Wendy DonaughBillings$3K
- Payton O'TooleBillings$3K
- Christina RicheyBillings$3K
- Kami WinnickiBillings$2K
- Taylor RicheyBillings$2K
- Amanda MurrayGreat Falls$101K
- Kara AddisonHelena$50K
- Mara ZelloBozeman$31K
- Michelle Weaver KnowlesMissoula$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.